Which companies are affected by this news?

Companies directly affected include: SAN, TCRX.

Which industries does this news affect?

AlphaOS tracks industry-level impact for all major market events.

Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies

Q: What is the market impact of: Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies?

AlphaOS is tracking this market event: Cellares and TScan Therapeutics Announce Agreement to Evaluate Automated Manufacturing of TSC-101 for Patients with Hematologic Malignancies.

July 10, 2026 · Updated Jul 10, 2026

Affected Companies

SAN69 ▼3

Banco Santander, S.A.

$13.89$203.96B cap

TCRX41

TScan Therapeutics, Inc.

$0.93$22.20M cap

AlphaOS aggregates and analyzes market news to extract structured investment intelligence. Content is for research and education only — not investment advice.